Follow @TheHPRA
Contact us
As Gaeilge
My HPRA:
Login
Register
About Us
Medicines
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Medicines
Safety Notices
My HPRA:
Login
Register
About Us
Medicines
COVID-19 vaccines and treatments
Our Role
Medicines Information
Safety Information
Safety Notices
Quality Information
Regulatory Information
News & Events
Special Topics
Emergency Medicines
Emergency Contact Details
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
TAMIFLU powder for oral suspension - Important Safety Information from Roche Products (Ireland) as approved by the Irish Medicines Board
Notice type:
3rd Party Publications
Date:
24/10/2012
Problem Or Issue:
Important Safety Information communication from Roche Products (Ireland) on new concentration and dosing instructions for TAMIFLU powder for oral suspension
Important Safety Information - TAMIFLU powder for oral suspension
Updated product information - Tamiflu powder for oral suspension - Summary of Product Characteristics
Updated product information - Tamiflu powder for oral suspension - Package Leaflet
« Back
Date Printed: 15/05/2024